Federal Alzheimer's Plan Update Prioritizes Prevention and Care
The U.S. Department of Health and Human Services updated the National Alzheimer's Plan on Thursday, introducing four new goals focused on risk reduction, treatment, research, and caregiver support, backed by up to $48.8 million in new federal investments.
The Department of Health and Human Services unveiled a major update to the National Plan to Address Alzheimer’s Disease and Related Dementias on Thursday. The 2026 update replaces six previous goals with four new ones: promoting dementia risk reduction across the lifespan, improving disease treatment and care, accelerating research into prevention and treatment, and strengthening support for caregivers.
HHS Secretary Robert F. Kennedy Jr. framed the shift. "Under President Trump, HHS is shifting the national strategy toward prevention, earlier detection, and faster development of better diagnostics and treatments," he said. The plan aims to raise awareness of risk factors, improve care for individuals, expand access to lifestyle interventions to slow decline, and promote dignity for patients and families.
Federal Funding and Initiatives
New federal initiatives and funding are central to the updated strategy. The Advanced Research Projects Agency for Health (ARPA-H) is investing up to $48.8 million in projects focused on earlier detection and intervention. Specific awards include $41 million to Mass General Brigham for a multi-institutional Alzheimer's disease platform trial and $2.75 million to support research at the University of California San Francisco.
Concurrently, the Food and Drug Administration launched the Alzheimer’s Prevention Accelerator. This program is part of the agency's Neuroscience Advancement and Innovation Nexus, or NAIN.
Caregiver and Community Support
The update strongly emphasizes supporting caregivers and communities. The Administration for Community Living will expand brain health resources and training for elder justice professionals like lawyers and social workers. Other initiatives will expand dementia training and screening, develop behavioral health resources, and strengthen public health approaches to the condition.
The plan includes studying diagnostic delays and the economic burden of dementia. It will also review prevention evidence and test a lifestyle intervention for mild cognitive impairment. CMS administrator Dr. Mehmet Oz stated that these initiatives will ease the burden on caregivers and expand access to lifestyle medicine interventions to slow cognitive decline.
Expert and Advocacy Response
The Alzheimer's Association welcomed the administration's focus on accelerating innovation and ensuring scientific advances translate into better care. The group also stressed the importance of access. The association said: "Progress of this kind makes a difference only when people can get access to it."
To that end, the Alzheimer's Association urged Congress to pass the bipartisan ASAP Act. The goal is to help Medicare beneficiaries benefit from newly available Alzheimer's blood-based biomarker testing.
